期刊文献+

瑞舒伐他汀通过抑制AMP活化蛋白激酶/Nod样受体热蛋白结构域相关蛋白3途径减轻高糖诱导的血管内皮功能障碍研究 被引量:3

Rosuvastatin protects against high glucose-induced endothelial dysfunction via the AMP-activated protein kinase/Nod-like receptor pyrin domain containing 3 pathway
原文传递
导出
摘要 目的探讨瑞舒伐他汀(RST)在高糖(HG)诱导的人脐静脉内皮细胞(HUVECs)中对Nod样受体热蛋白结构域相关蛋白3(NLRP3)炎症小体激活的调节作用及机制。方法建立HG诱导HUVECs体外模型,细胞分为正常葡萄糖+RST 0(Con)、2(RST 2)、5(RST 5)、10(RST 10)、20(RST 20)、30μmol/L(RST 30)组和HG+RST 0(HG)、2(HG+RST 2)、5(HG+RST 5)、10(HG+RST 10)、20(HG+RST 20)、30μmol/L(HG+RST 30)组。细胞转染实验增加HG+RST10+si-MP活化蛋白激酶(AMPK)组。采用四甲基偶氮唑盐微量酶反应比色法(MTT)法检测细胞活力,H2DCFDA荧光探针检测细胞内活性氧水平,Western blot分析AMPK/NLRP3途径蛋白表达,ELISA法测定上清液IL-1β和IL-18水平。结果HG+RST 5、HG+RST 10组改善HG诱导的细胞损伤,用于后续实验。与HG组比较,HG+RST 5、HG+RST 10组活性氧簇、IL-1β、IL-18水平及NADPH氧化酶4(NOX4)、硫氧还蛋白相互作用蛋白、NLRP3、半胱天冬酶1(Caspase-1)蛋白表达水平降低(P<0.05或P<0.01),p-AMPK/AMPK水平蛋白表达水平升高(P<0.05或P<0.01)。与HG+RST 10组比较,HG+RST10+si-AMPK组NLRP3、Caspase-1蛋白表达水平及IL-1β、IL-18水平升高(P<0.05或P<0.01),p-AMPK/AMPK蛋白表达水平降低(P<0.01)。结论瑞舒伐他汀通过激活AMPK磷酸化和抑制NLRP3炎症小体激活,缓解内皮炎症和氧化应激。 Objective To investigate the effects of Rosuvastatin(RST)on high glucose(HG)-induced NLRP3 inflammasome activation in Human Umbilical Vein Endothelial Cells(HUVECs)and explore the underlying mechanisms.Methods In vitro model of HUVECs induced by HG was established.Cells were divided into normal glucose+RST 0(Con),2(RST 2),5(RST 5),10(RST 10),20(RST 20),30μmol/L(RST 30)group and high glucose+RST 0(HG),2(HG+RST 2),5(HG+RST 5),10(HG+RST 10),20(HG+RST 20),30μmol/L(HG+RST 30)group.HG+RST 10+si-AMPK group was added in cell transfection experiment.Cell viability was detected by MTT assay,ROS level in cells was detected by H2 DCFDA fluorescent probe,AMPK/NLRP3 pathway protein expression was analyzed by Western blot,and IL-1βand IL-18 levels in supernatant were measured by ELISA.Results HG+RST 5,HG+RST 10 improved HG-induced cell damage,which was used in subsequent experiments.Compared with HG group,the levels of ROS,IL-1β,IL-18 and the protein expressions of NOX4,TXNIP,NLRP3 and Caspase-1 decreased(P<0.05 or P<0.01),while the protein expression level of p-AMPK/AMPK protein increased in HG+RST 5 and HG+RST 10 groups(P<0.05 or P<0.01).Compared with HG+RST 10 group,the expressions of NLRP3,Caspase-1 and IL-1β,IL-18 increased(P<0.05 or P<0.01),while the expressions of p-AMPK/AMPK protein decreased in Hg+RST 10+si-AMPK group(P<0.01).Conclusion Rosuvastatin can mitigate endothelial inflammation and oxidative stress by activating AMPK phosphorylation and inhibiting the NLRP3 inflammasome activation.
作者 张寿莉 都渝 ZHANG Shouli;DU Yu(Department of Endocrinology,Qinghai Specialized Hospital of Cardiovascular and Cerebrovascular Diseases,Xining 810012,China)
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2021年第10期774-780,共7页 Chinese Journal of Diabetes
基金 青海省医药卫生科技项目(2018-wjzdz-32)。
关键词 瑞舒伐他汀 高糖 人脐静脉内皮细胞 NLRP3炎症小体 AMP活化蛋白激酶 Rosuvastatin High glucose Human umbilical vein endothelial cells NLRP3 inflammasome AMPK
  • 相关文献

参考文献8

二级参考文献33

  • 1Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广(译),王淑敏(译),胡大一(校).极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志(中文版),2006,25(4):215-223. 被引量:348
  • 2Zhu J, Wang X, Chen J, et al. Reduced number and activity ofcirculating endothelial progenitor cells from patients with hyperhomo-cysteinemia[ J]. Arch Med Res,2006,37 (4) : 484 - 489.
  • 3Chen JZ, Zhu JH,Wang XX,et al. Effects of homocysteine onnumber and activity of endothelial progenitor cells from peripheralblood [J]. J Mol Cell Cardiol, 2004,36(2) : 233 -239.
  • 4Alam MM , Mohammad AA, Shuaib U, et al. Homocysteine reducesendothelial progenitor cells in stroke patients through apoptosis [ J].J Cereb Blood flow Metab, 2009,29(1) : 157 - 165.
  • 5Noor R, Shuaib U,Wang CX, et al. High-density lipoproteincholesterol regulates endothelial progenitor cells by increasing eNOSand preventing apoptosis[ J]. Atherosclerosis, 2007, 192(1) : 92 - 99.
  • 6Weiss N. Mechanisms of increased vascular oxidant stress in hyper-homocysteinemia and its impact on endothelial function [ J]. CurrDrug Metab,2005 , 6(1): 27 - 36.
  • 7Ungvari Z, Csiszar A, Edwards JG, et al. Increased superoxide pro-duction in coronary arteries in hyperhomocysteinemia : role of tumornecrosis factor-alpha, NADPH oxidase, and inducible nitric oxidesynthase [ J]. Arterioscler Thromb Vase Biol, 2003 , 23(3) : 418 -424.
  • 8Wassmann S,laufs U , Muller K,et al. Cellular antioxidant effectsof atorvastatin in vitro and in vivo [ J]. Arterioscler Thromb VaseBiol, 2002, 22(2) : 300 -305.
  • 9Bao XM, Wu Cf, lu GP. Atorvastatin inhibits homocysteine-z induced oxidative stress and apoptosis in endothelial progenitor cellsinvolving Nox4 and p38MAPK[ J]. Atherosclerosis, 2010 ( 1 ):114-121.
  • 10Ten freyhaus H, Huntgeburth M,Wingler K, et al. Novel Noxinhibitor VAS2870 attenuates PDGf-dependent smooth muscle cellchemotaxis, but not proliferation [ J]. Cardiovasc Res, 2006 , 71(2) : 331 -341.

共引文献124

同被引文献28

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部